Summary
My research focuses on health economic analyses of infectious diseases in low and middle-income countries. I specialize and have extensive experience in performing costings of healthcare interventions, cost of illness analysis and cost-effectiveness analysis. I work on projects on a wide range of infectious diseases (including neglected tropical diseases, dengue, HCV, HPV, hospital-acquired infections, and tetanus). I have conducted fieldwork in Ghana and Kenya and was based at a research unit in Vietnam for over three years. The goal of my research career is to use health economics to help optimise healthcare policy in low and middle-income countries.
Selected Publications
Journal Articles
Mathew CG, Bettis AA, Chu BK, et al. , 2020, The health and economic burdens of lymphatic filariasis prior to mass drug administration programs, Clinical Infectious Diseases, Vol:70, ISSN:1058-4838, Pages:2561-2567
Deribe K, Negussu N, Newport MJ, et al. , 2020, The health and economic burden of podoconiosis in Ethiopia, Transactions of the Royal Society of Tropical Medicine and Hygiene, Vol:114, ISSN:0035-9203, Pages:284-292
Turner HC, Lauer JA, Tran BX, et al. , 2019, Adjusting for inflation and currency changes within health economic studies, Value in Health, Vol:22, ISSN:1098-3015, Pages:1026-1032
Turner HC, Nguyen VH, Yacoub S, et al. , 2019, Achieving affordable critical care in low-income and middle-income countries, Bmj Global Health, Vol:4, ISSN:2059-7908, Pages:1-4
Turner HC, Toor J, Bettis AA, et al. , 2019, Valuing the unpaid contribution of community health volunteers to mass drug administration programs, Clinical Infectious Diseases, Vol:68, ISSN:1058-4838, Pages:1588-1595
Hung TM, Clapham HE, Bettis AA, et al. , 2018, The estimates of the health and economic burden of dengue in Vietnam, Parasitology Today, Vol:34, ISSN:0169-4758, Pages:904-918
Turner HC, Thwaites GE, Clapham HE, 2018, Vaccine-preventable diseases in lower-middle-income countries, Lancet Infectious Diseases, Vol:18, ISSN:1473-3099, Pages:937-939
Turner HC, Toor J, Hollingsworth TD, et al. , 2018, Economic evaluations of mass drug administration: the importance of economies of scale and scope, Clinical Infectious Diseases, Vol:66, ISSN:1058-4838, Pages:1298-1303
Turner HC, Bettis AA, Chu BK, et al. , 2017, Investment success in public health: an analysis of the cost-effectiveness and cost-benefit of the global programme to eliminate lymphatic filariasis, Clinical Infectious Diseases, Vol:64, ISSN:1058-4838, Pages:728-735
Turner HC, Truscott JE, Fleming FM, et al. , 2016, Cost-effectiveness of scaling up mass drug administration for the control of soil-transmitted helminths: a comparison of cost function and constant costs analyses., Lancet Infectious Diseases, Vol:16, ISSN:1473-3099, Pages:838-846
Turner HC, Truscott JE, Hollingsworth TD, et al. , 2015, Cost and cost-effectiveness of soil-transmitted helminth treatment programmes: systematic review and research needs., Parasites & Vectors, Vol:8, ISSN:1756-3305
Turner HC, Walker M, French MD, et al. , 2014, Neglected tools for neglected diseases: mathematical models in economic evaluations, Trends in Parasitology, Vol:30, ISSN:1471-4922, Pages:562-570
Turner HC, Walker M, Churcher TS, et al. , 2014, Reaching the London Declaration on Neglected Tropical Diseases Goals for Onchocerciasis: An Economic Evaluation of Increasing the Frequency of Ivermectin Treatment in Africa, Clinical Infectious Diseases, Vol:59, ISSN:1058-4838, Pages:923-932